SLA 0.00% $3.34 silk laser australia limited

Thanks for that great post Sav-J – reposting the post of Bob...

  1. 52 Posts.
    Thanks for that great post Sav-J – reposting the post of Bob Roberts from SS is a good reminder to us all how little data there is to support Solascam’s over-hyped claims (perhaps no surprise when they are led by a quack of the calibre of Vag with his scam clinic selling worthless homeopathic remedies, ‘60 minute instant photo’ aura clinic, and his ‘miracle’ fasting diets where the weight loss is entirely predicted by the energy deficit they create). That EGM presentation had everything in it….except evidence of any efficacy of the 101 indications they are pursuing.

    If SLA is to really make a go of it as a company and make profits to support future price projections, then it is the medical community that needs to be convinced that BioAlphabets are an effective alternative so they are prescribed. At present SLA are doing few favours to shareholders by being up front about their questionable results. Despite all the disease curing claims made by the Board and posters on discussion boards such as these, SLA's data are woefully short. They need to come out with some hard data showing that Ropren has clinical efficacy in treating liver disease. Until then all the pricing info they put out is just an academic exercise hence the SLA brainwashed should build that into your future SP projections at peril as the Western world won't be paying thousands of dollars for a treatment that doesn't have clinical efficacy data behind it when, as pointed out very clearly by billwillaims, there are far, far cheaper options around. Blood test results just aren’t going to cut it – need biopsies showing cellular changes in hepatocyte function and liver morphology to support claims that it cures liver disease and SLA just don’t have that data. The medical community aren’t as brainwashed and easily misled as some SLA ‘true believers’ who when confronted by a hard questions from people clearly with more expertise in the field than themselves revert to the tired old chant of ‘downramper' or 'go do some research'.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.